相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren
Tuija Tapaninen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Pharmacokinetics of Intravenous Paracetamol in Elderly Patients
Antti Liukas et al.
CLINICAL PHARMACOKINETICS (2011)
Mechanism-Based Inactivation of CYP2C8 by Gemfibrozil Occurs Rapidly in Humans
J. Honkalammi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations
Anne M. Filppula et al.
DRUG METABOLISM AND DISPOSITION (2011)
Dose-Dependent Interaction between Gemfibrozil and Repaglinide in Humans: Strong Inhibition of CYP2C8 with Subtherapeutic Gemfibrozil Doses
Johanna Honkalammi et al.
DRUG METABOLISM AND DISPOSITION (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
Acute Dapsone Intoxication: Clinical Findings and Effect of Oral Charcoal and Haemodialysis on Dapsone Elimination
P. J. NEUVONEN et al.
ACTA MEDICA SCANDINAVICA (2010)
SLCO1B1 Polymorphism and Oral Antidiabetic Drugs
Annikka Kalliokoski et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Grapefruit Juice Enhances the Exposure to Oral Oxycodone
Tuija H. Nieminen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast
T. Karonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Grapefruit Juice Greatly Reduces the Plasma Concentrations of the OATP2B1 and CYP3A4 Substrate Aliskiren
T. Tapaninen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin
Jenni E. Keskitalo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
J. E. Keskitalo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
CYP2C8 Activity Recovers within 96 Hours after Gemfibrozil Dosing: Estimation of CYP2C8 Half-Life Using Repaglinide as an in Vivo Probe
Janne T. Backman et al.
DRUG METABOLISM AND DISPOSITION (2009)
Voriconazole drastically increases exposure to oral oxycodone
Nora M. Hagelberg et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simastatin
Jenni E. Keskitalo et al.
PHARMACOGENOMICS (2009)
No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
Annikka Kalliokoski et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin
Pertti J. Neuvonen et al.
CLINICAL PHARMACOKINETICS (2008)
The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: Evidence for mechanism-based inhibition of CYP2C8 in vivo
A. Tornio et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
ABCB1 haplotypes differentially affect the pharmacokinetics of the acid and lactone forms of simvastatin and atorvastatin
J. E. Keskitalo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Plasma concentrations of oral oxycodone are greatly increased in the elderly
A. Liukas et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide
Annikka Kalliokoski et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate
Marja K. Pasanen et al.
PHARMACOGENETICS AND GENOMICS (2008)
Global analysis of genetic variation in SLCOIB1
Marja K. Pasanen et al.
PHARMACOGENOMICS (2008)
Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine
V-V Hynninen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Trimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazone
Aleksi Tornio et al.
DRUG METABOLISM AND DISPOSITION (2008)
Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin
M. K. Pasanen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam - Probes of CYP2C9, CYP1A2, and CYP3A4
J. J. Lilja et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics
L. Becquemont et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Marja K. Pasanen et al.
PHARMACOGENETICS AND GENOMICS (2006)
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
Pertti J. Neuvonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: Implications for in vitro prediction of drug interactions
Marjo J. Karjalainen et al.
DRUG METABOLISM AND DISPOSITION (2006)
Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life
Teijo I. Saari et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin
Mikko Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine
JT Backman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide
M Niemi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population
Marja K. Pasanen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects
Janne T. Backman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Cyclosporine markedly raises the plasma concentrations of repaglinide
LI Kajosaari et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2
MT Granfors et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone
T Jaakkola et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects
JJ Lilja et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Out-of-hospital administration of activated charcoal by emergency medical services
AO Alaspää et al.
ANNALS OF EMERGENCY MEDICINE (2005)
The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects
M Niemi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Fluvoxamine drastically increases concentrations and effects of tizanidine: A potentially hazardous interaction
MT Granfors et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Orange juice substantially reduces the bioavailability of the β-adrenergic-blocking agent celiprolol
JJ Lilja et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro
MT Granfors et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid
M Ucar et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects
C Kyrklund et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)
M Niemi et al.
PHARMACOGENETICS (2004)
Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin
JJ Lilja et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism
MT Granfors et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression
M Hedman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Gemfibrozil considerably increases the plasma concentrations of rosiglitazone
M Niemi et al.
DIABETOLOGIA (2003)
Pharmacokinetics and pharmacodynamics of pravastatin in children with-familial hypercholesterolemia
M Hedman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance
C Kyrklund et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide
M Niemi et al.
DIABETOLOGIA (2003)
Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol
JJ Lilja et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes
JS Wang et al.
DRUG METABOLISM AND DISPOSITION (2002)
Gemfibrozil greatly increases plasma concentrations of cerivastatin
JT Backman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole
K Raaska et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Drug-related deaths in a university central hospital
L Juntti-Patinen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively
X Wen et al.
DRUG METABOLISM AND DISPOSITION (2002)
Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs
O Lapatto-Reiniluoto et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate
C Kyrklund et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations
C Kyrklund et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect
T Varis et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin
JJ Lilja et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Morphine clearance and effects in newborn infants in relation to gestational age
E Saarenmaa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Plasma concentrations of active simvastatin acid are increased by gemfibrozil
JT Backman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Effect of grapefruit juice dose on grapefruit juice-triazolam interaction:: repeated consumption prolongs triazolam half-life
JJ Lilja et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Efficacy of activated charcoal versus gastric lavage half an hour after ingestion of moclobemide, temazepam, and verapamil
O Lapatto-Reiniluoto et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Grapefruit juice can increase the plasma concentrations of oral methylprednisolone
T Varis et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone
T Varis et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
